Crenezumab for Prodromal to Mild Alzheimer's Disease
Language
Undefined
Purpose: To test the experimental drug crenezumab in people with early to mild Alzheimer's disease.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials